Vaassen Femke, Hofstede David, Birimac Nikolina, Compter Inge, Granzier Marlies, van Elmpt Wouter, M L Zegers Catharina, B P Eekers Daniëlle
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Phys Imaging Radiat Oncol. 2025 Aug 30;35:100830. doi: 10.1016/j.phro.2025.100830. eCollection 2025 Jul.
Movement of optical structures during radiotherapy for tumors near the orbita might affect the amount of radiation given and consequently the risk for side effects. The aim of this study was therefore to quantify motion of optical structures during radiotherapy.
Twenty brain tumor patients were retrospectively included, with planning computed tomography (CT)-scan (pCT) and five repeat-CT-scans (reCTs) without gazing instructions. Six optical structures were delineated bilaterally: lens, cornea, retina, lacrimal glands, macula, and optic nerves (ON). The ON was split in three subregions. The dice similarity coefficient (DSC), absolute distance (AD), and difference in 3D midpoint (ΔMP) were calculated between pCT and reCT. Planning risk volume (PRV)-margins and isotropic expansions to cover 95 % volume for 90 % patients were calculated. A dose-volume proof-of-principle was performed for a neurological and nasopharyngeal tumor.
Highest median ΔMP was found for the cornea: 1.9 mm. For ON subregions, highest median and 95th-percentile ΔMP was found for proximal intra-orbital ON: 1.3 mm and 3.1 mm. ON showed highest median AD: 3.0 mm (negative Z-direction). Open eyelid status resulted in statistically significant lower DSC for ON, intra-cranial ON, and proximal intra-orbital ON, and higher ΔMP for proximal intra-orbital ON. 1-4 mm isotropic expansions were needed for separate structures, dependent on typical movement range. Higher dose-differences were found for the neurological than the nasopharyngeal plan.
The observed movement of optical structures indicated that a PRV-margin should be considered in clinical practice. Asking the patient to close their eyes during the treatment could decrease the movement.
对于眼眶附近肿瘤进行放射治疗期间,眼部结构的移动可能会影响所给予的辐射剂量,进而影响出现副作用的风险。因此,本研究的目的是量化放射治疗期间眼部结构的移动情况。
回顾性纳入20例脑肿瘤患者,有计划计算机断层扫描(CT)(pCT)以及5次无注视指令的重复CT扫描(reCT)。双侧勾勒出6个眼部结构:晶状体、角膜、视网膜、泪腺、黄斑和视神经(ON)。视神经被分为三个子区域。计算pCT和reCT之间的骰子相似系数(DSC)、绝对距离(AD)和三维中点差异(ΔMP)。计算计划风险体积(PRV)边界以及覆盖90%患者95%体积的各向同性扩展。对1例神经肿瘤和1例鼻咽癌进行了剂量体积原理验证。
角膜的中位ΔMP最高:1.9毫米。对于视神经子区域,眶内近端视神经的中位ΔMP和第95百分位数最高:1.3毫米和3.1毫米。视神经的中位AD最高:3.0毫米(Z轴负向)。睁眼状态导致视神经、颅内段视神经和眶内近端视神经的DSC在统计学上显著降低,而眶内近端视神经的ΔMP更高。根据典型移动范围,单独结构需要1 - 4毫米的各向同性扩展。神经肿瘤计划的剂量差异高于鼻咽癌计划。
观察到的眼部结构移动表明,临床实践中应考虑PRV边界。要求患者在治疗期间闭眼可减少移动。